StockData
NeuroSense Therapeutics Ltd. logo

NeuroSense Therapeutics Ltd. (NRSN) KPIs and segments

NRSNNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as NRSNW
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 4/30
$1.51−0.05 (-3.51%)

Close on Nov 17, 2026Market cap $2.77MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive NeuroSense Therapeutics's business

Coming soon

This tab will track the numbers specific to NeuroSense Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?